Literature DB >> 10521162

The economic cost of Alzheimer's disease and related dementias to the California Medicaid program ("Medi-Cal") in 1995.

J Menzin1, K Lang, M Friedman, P Neumann, J L Cummings.   

Abstract

Although state Medicaid programs may bear a large portion of the costs of Alzheimer's disease (AD), current information on spending is not available. Using a health insurance claims database for a 10% random sample of California Medicaid ("Medi-Cal") recipients 60+ years of age, the authors estimated the excess cost of AD to Medi-Cal in 1995 as the difference in expenditures between an AD cohort (those with AD or related dementias) and an age- and sex-matched cohort without AD. Among 62,450 recipients, 2,575 (4.1%) were found to have AD or related dementias, and their average payments were approximately $7,700 higher (P<0.01) than those for the comparison group. These estimates suggest that Medi-Cal spends about $200 million on AD and related dementias annually, a burden that represents nearly 10% of state spending on elderly patients.

Entities:  

Mesh:

Year:  1999        PMID: 10521162

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  11 in total

Review 1.  A systematic review to assess the policy-making relevance of dementia cost-of-illness studies in the US and Canada.

Authors:  Mark Oremus; S Carolina Aguilar
Journal:  Pharmacoeconomics       Date:  2011-02       Impact factor: 4.981

2.  Medicaid Contributes Substantial Costs to Dementia Care in an Ethnically Diverse Community.

Authors:  Carolyn W Zhu; Katherine A Ornstein; Stephanie Cosentino; Yian Gu; Howard Andrews; Yaakov Stern
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-08-13       Impact factor: 4.077

3.  Health-care use and cost in dementia caregivers: Longitudinal results from the Predictors Caregiver Study.

Authors:  Carolyn W Zhu; Nikolaos Scarmeas; Katherine Ornstein; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2014-03-15       Impact factor: 21.566

4.  Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community.

Authors:  Carolyn W Zhu; Nikolaos Scarmeas; Rebecca Torgan; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  J Am Geriatr Soc       Date:  2006-10       Impact factor: 5.562

5.  The effects of patient function and dependence on costs of care in Alzheimer's disease.

Authors:  Carolyn W Zhu; Christopher Leibman; Trent McLaughlin; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

6.  Sensitivity of nursing home cost comparisons to method of dementia diagnosis ascertainment.

Authors:  Ann L Gruber-Baldini; Bruce Stuart; Ilene H Zuckerman; Van Doren Hsu; Kenneth S Boockvar; Sheryl Zimmerman; Steven Kittner; Charlene C Quinn; J Richard Hebel; Conrad May; Jay Magaziner
Journal:  Int J Alzheimers Dis       Date:  2009-09-22

7.  Patient dependence and longitudinal changes in costs of care in Alzheimer's disease.

Authors:  Carolyn W Zhu; Christopher Leibman; Trent McLaughlin; Arthur S Zbrozek; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Dement Geriatr Cogn Disord       Date:  2008-10-22       Impact factor: 2.959

8.  Home health and informal care utilization and costs over time in Alzheimer's disease.

Authors:  Carolyn W Zhu; Rebecca Torgan; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Home Health Care Serv Q       Date:  2008

9.  Dementia and Medicare at life's end.

Authors:  Vicki L Lamb; Frank A Sloan; Anil S Nathan
Journal:  Health Serv Res       Date:  2008-04       Impact factor: 3.402

10.  Direct medical costs in patients with Alzheimer's disease in Taiwan: A population-based study.

Authors:  Agnes L F Chan; Thau-Ming Cham; Shun-Jin Lin
Journal:  Curr Ther Res Clin Exp       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.